Treatment of Central Serous Chorioretinopathy With Topical Difluprednate: A Literature Review. [PDF]
CureusChatterjee SK, Khuddus N.
europepmc +1 more source
Subtype-specific shifts in age, axial length, and clinical profile of neovascular age-related macular degeneration: a five-year study in Japan. [PDF]
Jpn J OphthalmolAkada M +7 more
europepmc +1 more source
Short-term outcomes and choroidal morphological changes following aflibercept therapy in pachychoroid neovasculopathy. [PDF]
Sci RepKim JH +5 more
europepmc +1 more source
Choroidal neovascularization as a trigger for central serous chorioretinopathy. [PDF]
Int J Retina VitreousVienne-Jumeau A +4 more
europepmc +1 more source
Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance. [PDF]
PLoS OneYoshinaga A +6 more
europepmc +1 more source
Characteristics of geographic atrophy secondary to age-related macular degeneration in Korean patients. [PDF]
BMC OphthalmolPark SM, Shin D, Kim CG, Kim JH.
europepmc +1 more source
SMACH: A Rare, Non-Progressive Retinal Disorder - Key Insights into Its Clinical and Imaging Characteristics. A Case Report. [PDF]
Rom J OphthalmolArango-Hurtado M +4 more
europepmc +1 more source
Characteristics and Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in a Large Cohort of Patients with Pachychoroid Neovasculopathy. [PDF]
J Vitreoretin DisAizouki C +7 more
europepmc +1 more source
Early retinal volume changes after switching to brolucizumab in refractory neovascular age-related macular degeneration. [PDF]
Front Ophthalmol (Lausanne)Matsuki T +4 more
europepmc +1 more source
Clinical Features and Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration and Pachychoroid Neovasculopathy. [PDF]
J Vitreoretin DisKhaohoen A, Chantarasorn Y.
europepmc +1 more source